Niederhuber John 4
4 · Aptevo Therapeutics Inc. · Filed Jun 3, 2022
Insider Transaction Report
Form 4
Niederhuber John
Director
Transactions
- Exercise/Conversion
Common Stock
2022-06-01+298→ 1,814 total - Purchase
Common Stock
2019-06-14$0.91/sh+714$650→ 1,516 total - Exercise/Conversion
Restricted Stock Unit
2022-06-01−298→ 595 total→ Common Stock (298 underlying)
Holdings
- 802
Common Stock
Footnotes (4)
- [F1]Shares received in a pro rata distribution by Emergent BioSolutions Inc. ("Emergent") as a result of the spin-off of the Issuer from Emergent, effective August 1, 2016, and adjusted to reflect a 1-for-14 reverse stock split of the Issuer's common stock effective as of March 26, 2020.
- [F2]Reflects a 1-for-14 reverse stock split of the Issuer's common stock effective as of March 26, 2020.
- [F3]Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
- [F4]On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022.